Hemodynamic support with the Impella acute 100 in patients with cardiogenic chock, or high-risk coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI)

Ítems similars

• Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
  per: Dalal, Pratik K., et al.
  Publicat: (2019)
• Percutaneous Coronary Intervention (PCI) Strategies under Hemodynamic Support for Cardiogenic Shock: A Single-Center Experience with Two Patients
  per: Ahmed, Talha, et al.
  Publicat: (2020)
• Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis? —a review of the evidences on coronary artery disease
  per: Spadaccio, Cristiano, et al.
  Publicat: (2018)
• Use of Impella 2.5 in Patient with Multi-Vessel Percutaneous Coronary Intervention and Cardiogenic Shock
  per: Doshi, Rajkumar, et al.
  Publicat: (2017)
• Revascularisation for acute coronary syndromes: PCI or CABG?
  per: Gunn, J, et al.
  Publicat: (2003)